|
WO1999000113A1
(en)
*
|
1997-06-27 |
1999-01-07 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20070116761A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
DK1585548T3
(en)
*
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
|
CN103169729A
(zh)
|
2005-02-18 |
2013-06-26 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
CN101291658B
(zh)
*
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
US7771751B2
(en)
|
2005-08-31 |
2010-08-10 |
Abraxis Bioscience, Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
|
WO2008000079A1
(en)
*
|
2006-06-26 |
2008-01-03 |
The University Of British Columbia |
Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
|
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
WO2008057329A2
(en)
*
|
2006-11-01 |
2008-05-15 |
George Mason Intellectual Properties, Inc. Of Fairfax, Virginia |
Method for detecting and controlling cancer
|
|
US9675578B2
(en)
|
2006-12-14 |
2017-06-13 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
EP3417859A1
(en)
*
|
2007-03-07 |
2018-12-26 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
WO2008137148A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Methods and compositions for treating pulmonary hypertension
|
|
AU2008260447B2
(en)
*
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
CN101677987A
(zh)
*
|
2007-06-22 |
2010-03-24 |
赛多斯有限责任公司 |
不含吐温80的多西他赛的增溶制剂
|
|
ITMI20080284A1
(it)
*
|
2008-02-22 |
2009-08-23 |
Indena Spa |
Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
|
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
EP3266453A1
(en)
|
2008-07-03 |
2018-01-10 |
Mayo Foundation for Medical Education and Research |
Treating cancer
|
|
EP2153821A1
(en)
*
|
2008-08-06 |
2010-02-17 |
BioAlliance Pharma |
Oral formulations of camptothecin derivatives
|
|
BRPI1007046B1
(pt)
*
|
2009-01-16 |
2019-07-16 |
Rigel Pharmaceuticals, Inc. |
Inibidores axl para uso em terapia de combinação para evitar, tratar ou controlar o câncer metastático.
|
|
BRPI1008955A2
(pt)
|
2009-03-13 |
2015-09-01 |
Abraxis Bioscience Llc |
Terapia de combinação com derivados de tiocolchicina.
|
|
HRP20192259T1
(hr)
|
2009-04-15 |
2020-03-06 |
Abraxis Bioscience, Llc |
Pripravci nanočestica bez priona i metode njihove proizvodnje
|
|
WO2011005886A1
(en)
*
|
2009-07-07 |
2011-01-13 |
Normoxys, Inc. |
Method of reducing multi-drug resistance using inositol tripyrophosphate
|
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
|
SG10201401123VA
(en)
*
|
2010-02-23 |
2014-08-28 |
Genentech Inc |
Anti-Angiogenesis Therapy For The Treatment Of Ovarian Cancer
|
|
CA3051495A1
(en)
|
2010-03-26 |
2011-09-29 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
|
KR20130028727A
(ko)
*
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
|
US9393318B2
(en)
*
|
2010-03-29 |
2016-07-19 |
Abraxis Bioscience, Llc |
Methods of treating cancer
|
|
KR20130088116A
(ko)
|
2010-06-04 |
2013-08-07 |
아브락시스 바이오사이언스, 엘엘씨 |
췌장암의 치료 방법
|
|
CA2801891C
(en)
*
|
2010-06-07 |
2020-10-27 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
|
US20120121510A1
(en)
*
|
2010-11-11 |
2012-05-17 |
Brem Rachel F |
Localized therapy following breast cancer surgery
|
|
US20130323265A1
(en)
*
|
2010-11-15 |
2013-12-05 |
Oncomed Pharmaceuticals, Inc. |
Methods for treating cancer with dll4 antagonists
|
|
HUE048876T2
(hu)
|
2011-05-09 |
2020-08-28 |
Mayo Found Medical Education & Res |
Rákos megbetegedések kezelése
|
|
JP6162709B2
(ja)
|
2011-11-01 |
2017-07-12 |
セルジーン コーポレイション |
シチジンアナログの経口製剤を使用して癌を治療する方法
|
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
|
PL2790675T3
(pl)
|
2011-12-14 |
2019-12-31 |
Abraxis Bioscience, Llc |
Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
|
|
PL2825558T3
(pl)
|
2012-03-13 |
2019-11-29 |
Hoffmann La Roche |
Terapia skojarzona w leczeniu raka jajnika
|
|
US10413606B2
(en)
|
2012-10-01 |
2019-09-17 |
Mayo Foundation For Medical Education And Research |
Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US9511046B2
(en)
*
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
WO2014123612A1
(en)
*
|
2013-02-11 |
2014-08-14 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
JP6349381B2
(ja)
|
2013-03-12 |
2018-06-27 |
アブラクシス バイオサイエンス， エルエルシー |
肺がんを処置する方法
|
|
JP6309610B2
(ja)
|
2013-03-14 |
2018-04-11 |
アブラクシス バイオサイエンス， エルエルシー |
膀胱がんを処置する方法
|
|
US10842969B2
(en)
|
2013-10-25 |
2020-11-24 |
Mercator Medsystems, Inc. |
Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
|
|
WO2015134543A1
(en)
*
|
2014-03-05 |
2015-09-11 |
Sorrento Therapeutics, Inc. |
Pharmacokinetically equivalent nanoparticle compositions
|
|
EP2924022A1
(en)
*
|
2014-03-27 |
2015-09-30 |
INDENA S.p.A. |
Amorphous form of a thiocolchicine derivative
|
|
EP3154586B1
(en)
|
2014-06-13 |
2020-05-27 |
Mayo Foundation for Medical Education and Research |
Treating lymphomas
|
|
US10213513B2
(en)
|
2014-06-16 |
2019-02-26 |
Mayo Foundation For Medical Education And Research |
Treating myelomas
|
|
US20150359810A1
(en)
|
2014-06-17 |
2015-12-17 |
Celgene Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
|
CN104434808A
(zh)
*
|
2014-07-03 |
2015-03-25 |
石药集团中奇制药技术（石家庄）有限公司 |
一种治疗性纳米粒子及其制备方法
|
|
CN107073132B
(zh)
*
|
2014-10-06 |
2021-08-27 |
梅约医学教育与研究基金会 |
载体-抗体组合物及其制备和使用方法
|
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
|
SMT202100642T1
(it)
|
2015-06-29 |
2022-03-21 |
Abraxis Bioscience Llc |
Nanoparticelle comprendenti sirolimus e un'albumina per l'uso nel trattamento di tumori a cellule epitelioidi
|
|
TW201707725A
(zh)
|
2015-08-18 |
2017-03-01 |
美國馬友醫藥教育研究基金會 |
載體－抗體組合物及其製造及使用方法
|
|
WO2017176265A1
(en)
*
|
2016-04-06 |
2017-10-12 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
JP6921802B2
(ja)
*
|
2015-08-18 |
2021-08-18 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ Ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ |
キャリア結合剤組成物およびそれを作製および使用する方法
|
|
TW201713360A
(en)
|
2015-10-06 |
2017-04-16 |
Mayo Foundation |
Methods of treating cancer using compositions of antibodies and carrier proteins
|
|
CN105288639A
(zh)
*
|
2015-11-23 |
2016-02-03 |
中国药科大学 |
一种载阿霉素的主动靶向白蛋白纳米载体的制备及其应用
|
|
WO2017120501A1
(en)
|
2016-01-07 |
2017-07-13 |
Mayo Foundation For Medical Education And Research |
Methods of treating cancer with interferon
|
|
US11351254B2
(en)
|
2016-02-12 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
Hematologic cancer treatments
|
|
EP3432928A4
(en)
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
PROCESS FOR IMPROVING THE THERAPEUTIC INDEX FOR CHEMOTHERAPEUTIC
|
|
WO2017165440A1
(en)
*
|
2016-03-21 |
2017-09-28 |
Mayo Foundation For Medical Education And Research |
Methods for reducing toxicity of a chemotherapeutic drug
|
|
US10618969B2
(en)
|
2016-04-06 |
2020-04-14 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
|
KR102482503B1
(ko)
*
|
2016-08-05 |
2022-12-30 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
암 치료를 위한 변형된 항체-알부민 나노입자 복합체
|
|
TWI771315B
(zh)
*
|
2016-08-26 |
2022-07-21 |
奧野哲治 |
微小奈米化藥劑及其利用
|
|
CN109843336A
(zh)
|
2016-09-01 |
2019-06-04 |
梅约医学教育与研究基金会 |
用于靶向t细胞癌症的方法和组合物
|
|
CN109890419A
(zh)
|
2016-09-01 |
2019-06-14 |
梅约医学教育与研究基金会 |
用于治疗癌症的载体-pd-l1结合剂组合物
|
|
US11590098B2
(en)
|
2016-09-06 |
2023-02-28 |
Mayo Foundation For Medical Education And Research |
Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins
|
|
AU2017324947A1
(en)
|
2016-09-06 |
2019-03-28 |
Mayo Foundation For Medical Education And Research |
Paclitaxel-albumin-binding agent compositions and methods for using and making the same
|
|
CN109843924A
(zh)
|
2016-09-06 |
2019-06-04 |
梅约医学教育与研究基金会 |
治疗表达pd-l1的癌症的方法
|
|
CN106310291A
(zh)
*
|
2016-09-14 |
2017-01-11 |
东南大学 |
主动靶向抗肿瘤纳米药物及其制备方法和应用
|
|
HUE058289T2
(hu)
|
2016-10-27 |
2022-07-28 |
Celgene Quanticel Res Inc |
Brómdomén és extraterminális protein inhibitor kombinációs terápia
|
|
WO2018081652A2
(en)
*
|
2016-10-28 |
2018-05-03 |
Nant Holdings Ip, Llc |
Avatar dendritic cells: the neoantigen natural killer t-cell chemo immuno radiation composition inducing immunogenic cell death
|
|
AU2018360766B2
(en)
|
2017-11-06 |
2024-09-19 |
Rapt Therapeutics, Inc. |
Anticancer agents
|
|
US20200390717A1
(en)
*
|
2017-11-21 |
2020-12-17 |
University Of Iowa Research Foundation |
Synthetically lethal nanoparticles for treatment of cancers
|
|
SG11202005613SA
(en)
*
|
2017-12-19 |
2020-07-29 |
Abraxis Bioscience Llc |
Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapy
|
|
US11524053B2
(en)
|
2018-01-26 |
2022-12-13 |
The Regents Of The University Of California |
Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
|
|
AU2019239953B2
(en)
|
2018-03-20 |
2025-01-02 |
Abraxis Bioscience, Llc |
Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin
|
|
IL292439B2
(en)
|
2019-10-28 |
2026-05-01 |
Abraxis Bioscience Llc |
Pharmaceutical preparations of albumin and rapamycin
|
|
CN114867487A
(zh)
|
2019-11-25 |
2022-08-05 |
加利福尼亚大学董事会 |
用于眼内新生血管的长效vegf抑制剂
|
|
KR102263606B1
(ko)
|
2020-02-11 |
2021-06-10 |
충북대학교 산학협력단 |
파클리탁셀과 알피늄이소플라본을 함유한 나노 마이셀, 이의 제조방법 및 이의 용도
|
|
US20260137674A1
(en)
|
2024-10-23 |
2026-05-21 |
Incyte Corporation |
Combination therapy using a kras g12d inhibitor, and a nucleoside analog, and/or a microtubule inhibitor
|